Zobrazeno 1 - 10
of 14
pro vyhledávání: '"David C. Ackley"'
Autor:
Matthew M. Abernathy, Malar Pannirselvam, Alysia A. Chaves, Annie Delaunois, Michael C. Foley, Jonathan Maher, Jean-Michel Guillon, Tom Monticello, Hugo M. Vargas, Bruce Damiano, Andrea Greiter-Wilke, Jon Renninger, David C. Ackley
Publikováno v:
Journal of Pharmacological and Toxicological Methods. 99:106595
Autor:
Magee Thomas Victor, Thuy-Trinh Nguyen, Joseph A. Abramite, Yue Shen, Jian Lin, Jiri Aubrecht, Fadia Dib-Hajj, Jeremy T. Starr, Alita A. Miller, Matthew Frank Brown, Shawn H. MacVane, Michael D. Huband, Li Zhang, Karl Granskog, Bryan Li, Jinshan Michael Chen, James M. McKim, John P. O'Donnell, Karen L. Leach, Paul C. Wilga, David P. Nicolau, Sandra P. McCurdy, Mark Edward Flanagan, Antonia F. Stepan, Andrew P. Tomaras, Mark C. Noe, Michael Kuhn, Scott B. Seibel, Rebecca Irvine, Jinfeng Xu, David C. Ackley, David R. Luke, Jared L. Crandon, Joel R. Hardink, Andrew Butler
Publikováno v:
Journal of Medicinal Chemistry. 56:5079-5093
We report novel polymyxin analogues with improved antibacterial in vitro potency against polymyxin resistant recent clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa . In addition, a human renal cell in vitro assay (hRPTEC) was
Autor:
Jacqueline H. Smith, Arthur W. Lington, James E. Klaunig, Jason S. Isenberg, George Pugh, Lisa M. Kamendulis, David C. Ackley
Publikováno v:
Toxicological Sciences. 56:73-85
The present study evaluated the effect of di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular communication (GJIC), peroxisomal beta-oxidation (PBOX) activity, and replicative DNA synthesis in several rodent species with differing suscep
Autor:
David C. Ackley, Jason S. Isenberg, Arthur W. Lington, James E. Klaunig, Ray Brown, Jacqueline H. Smith, Lisa M. Kamendulis, Lisa J. Clare, George Pugh
Publikováno v:
Toxicological Sciences. 56:181-188
The effects of the peroxisome proliferators di-isononyl phthalate (DINP) and di-2-ethylhexyl phthalate (DEHP) were evaluated in young adult male cynomolgus monkeys after 14 days of treatment, with emphasis on detecting hepatic and other effects seen
Autor:
David C. Ackley, Arthur W. Lington, Lisa M. Kamendulis, Jacqueline H. Smith, James E. Klaunig, Jason S. Isenberg, George Pugh
Publikováno v:
Toxicological Sciences. 54:312-321
The short-term hepatic effects of DINP (CAS 68515-48-0, designated DINP-1) in rats and mice were evaluated at tumorigenic and nontumorigenic doses from previous chronic studies. Groups of male F344 rats were fed diets with DINP-1 at concentrations of
Publikováno v:
Journal of Inorganic Biochemistry. 76:127-132
The extent, rate and possible mechanism(s) by which aluminum enters and is removed from the brain are presented. Introduction of Al into systemic circulation as Al.transferrin, the predominant Al species in plasma, resulted in about 7 x 10(-5) of the
Autor:
Nada G Chang, Robert A. Yokel, Joseph P. McGillis, David C Ackley, James W. Geddes, Natalie S Soultanian
Publikováno v:
Brain Research. 831:104-112
Postmortem alterations in the neuronal cytoskeleton resemble some aspects of the cytoskeletal disruption associated with neurodegenerative disorders, and are also similar to those observed following ischemia and produced by excitotoxins in vivo and i
Autor:
David C Ackley, Robert A. Yokel
Publikováno v:
Toxicology. 127:59-67
Blood–brain barrier transport of aluminum citrate was assessed in rats by microdialysis of the jugular vein as well as the right and left frontal cortices. Previous studies (Allen et al., 1995. Evidence for energy-dependent transport of aluminum ou
Autor:
Robert A. Yokel, David C Ackley
Publikováno v:
Toxicology. 120:89-97
Aluminum citrate transport across the blood-brain barrier was assessed in rats by in vivo microdialysis. Microdialysis probes were implanted in the jugular vein as well as the left and right frontal cortex. It was demonstrated previously (Allen et al
Publikováno v:
Drug and chemical toxicology. 37(2)
Polypeptide antibiotics, such as polymyxins and aminoglycosides, are essential for treatment of life-threatening Gram-negative infections. Acute kidney injury (AKI) attributed to treatment with these agents severely limits their clinical application.